- Harmony Biosciences set annual stockholder meeting for May 14, 2026, to be held virtually.
- Ballot includes election of four Class III directors to serve through 2029, including nominees Geno Germano, Troy Ignelzi, Ron Philip, Andreas Wicki.
- Shareholders also will vote on ratification of Deloitte & Touche as independent auditor for fiscal year 2026.
- Advisory vote scheduled on compensation for named executive officers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-039449), on April 03, 2026, and is solely responsible for the information contained therein.
Comments